SIRT3 and diabetic kidney disease: Across multiple models, activation of Sirt3 has been associated with inhibition of ferroptosis, corresponding to improved outcomes in diabetic nephropathy, reduced doxorubicin cardiotoxicity, and attenuation of femoral head osteonecrosis [42,43,44].